Xinhua News Agency, May 11, a number of companies issued lunchtime announcements, as follows: ① Coren Pharmaceutical Co., Ltd.: the application for listing of the company's holding subsidiary Columbine injection A166 (HER2-ADC) was accepted by NMPA, and the indication was drawn up: locally advanced, relapsed or metastatic breast cancer with HER2 positive after failure of second-line or above anti-HER2 treatment in the past. ② Zijian Electronics: Chongqing Viduli, the wholly-owned grandson of the company, and related parties Beijing Yunhui, Duan Aimin, non-related parties Biyi shares and a non-related party natural person jointly invested in the establishment of private equity fund Gongqingcheng Bihui. Gongqingcheng Bihui subscribed a total of 42 million yuan, of which Chongqing Viduli subscribed 6 million yuan, accounting for about 14.2857% of the capital contribution. The fund will focus on investing in unlisted companies at all stages of entrepreneurship in areas such as new energy and smart homes. ③ ST Sunshine City: the controlling shareholder of the company, Dongfang Xinlong and Kangtian Industries, whose shares in the company are 0.87% frozen by the Fuzhou Intermediate people's Court. ④ Funda Technology: 2.55% of the company's shares held by Xiao Fen, the company's controlling shareholder, are pledged. ⑤ Hongye Futures: 14.24% of the shares held by Hongsu Industries, the shareholder of the company, are re-frozen by the judiciary.